Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Great company! WEAK market cap ?'ble bullboard ;- (
View:
Post by SouthernTierTom on Jan 09, 2022 10:51am

Great company! WEAK market cap ?'ble bullboard ;- (

Almost as good as the political faux agenda that was applied months ago

Let's put a petition together as real retail holders that first asks and then suggests spending a few thousand dollars to do a virtual invester prezzie at one of the countless biotechnology shows running every month. A 54M mcap and a phase 2 with a FDA fastrack for a HUGE unmet need should easily warrant the cost of a 2010 chevy Cavalier.

Too bad this bullboard only gets " pumpy" when the SP is rising on volume, although it does allow the smart ones that bought at say, 19 cents CAD, to double their dough.

Looks like the latest "Sideshow Bob effort" is unrelated discussion around Vitamin D ( say vitamin like a Brit, it's fun, try it )

Always a silver lining or "pocket lining" somewhere

Do your own due diligence, the internet should NOT be trusted and feel free to include the farmer in that statement.
Comment by floatinketucky on Jan 09, 2022 11:23am
I have had this stock since 2014... Sold none!! I have always said ths sciece would be devolped.  And it is being devolped. The stock has made good moves with many more to come.  Folks would have been doing good to consider Theralse a few months ago. And its smart to consider Theralase now. They are on the rise!!!! They are only proofing the science more and more.  We are just ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250